Delivery Order 36C26319D0095-36C26321N0864
Award Date 8/23/21
Potential Completion Date 9/30/21
Potential Value $1.3K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
South San Francisco, CA 94080, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 23 awarded Tosoh Bioscience, Inc., doing business as Tosoh USA, a $10,023.44 firm fixed price delivery order against an indefinite-delivery, indefinite-quantity contract for glycated hemoglobin A1c (HbA1c or A1c) testing services. The contract has a period of performance through August 22, 2020 to support the VA's clinical care and health monitoring programs. Tosoh USA will provide HbA1c testing...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 23 awarded Tosoh Bioscience, Inc., doing business as Tosoh USA, a $6,286.70 firm fixed price delivery order against an indefinite-delivery, indefinite-quantity contract for glycated hemoglobin A1c (HbA1c or A1c) testing services. The delivery order, which does not contain a set-aside designation, calls for Tosoh Bioscience to provide cost-per-test A1c testing through September 30, 2022 to...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 23 awarded Tosoh Bioscience, Inc., doing business as Tosoh USA, an $11,676.70 firm fixed price delivery order against an indefinite-delivery, indefinite-quantity contract for glycated hemoglobin A1c (HbA1c or A1c) testing services. The delivery order, which does not have a set-aside designation, calls for Tosoh Bioscience to provide cost-per-test A1c testing through September 30, 2022 to support...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 23 awarded Tosoh Bioscience, Inc., doing business as Tosoh USA, a $3,443.72 firm fixed price delivery order against an indefinite-delivery, indefinite-quantity contract for glycated hemoglobin A1C testing. The delivery order, which does not have a set-aside designation, calls for Tosoh Bioscience to provide cost per test A1C testing services through September 30, 2021 for VISN 23,...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 23 awarded Tosoh Bioscience, Inc., doing business as Tosoh USA, a $17,713.50 firm fixed price delivery order against an indefinite-delivery, indefinite-quantity contract for glycated hemoglobin A1c (HbA1c or A1c) testing services. The contract has a period of performance through August 22, 2021 to provide cost-per-test HbA1c testing services to support VHA's efforts to monitor blood sugar levels...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 23 awarded Tosoh Bioscience, Inc., doing business as Tosoh USA, a $16,272.90 firm fixed price delivery order against an indefinite-delivery, indefinite-quantity contract for glycated hemoglobin A1c (HbA1c or A1c) testing services. The delivery order, which does not have a set-aside designation, calls for Tosoh Bioscience to provide cost-per-test A1c testing services through August 22, 2021 in...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 23 awarded Tosoh Bioscience, Inc., doing business as Tosoh USA, a $2,779.28 firm fixed price delivery order against an indefinite-delivery, indefinite-quantity contract for glycated hemoglobin A1c (HbA1c or A1c) testing services. Performance will occur in South San Francisco, California by September 30, 2021. This delivery order supports the VHA's efforts to monitor blood glucose levels in...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 23 awarded Tosoh Bioscience, Inc., doing business as Tosoh USA, a $5,642.84 firm fixed price delivery order against an indefinite-delivery, indefinite-quantity contract for glycated hemoglobin A1c (HbA1c or A1c) testing services. The contract has a period of performance through August 22, 2021 to provide cost-per-test A1c testing services to support VHA's clinical care and health monitoring...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 23 awarded Tosoh Bioscience, Inc., doing business as Tosoh USA, a $10,405.64 firm fixed price delivery order against an indefinite-delivery, indefinite-quantity contract for glycated hemoglobin A1c (HbA1c or A1C) testing services. The contract has a period of performance through August 2024 and calls for Tosoh Bioscience to provide cost-per-test HbA1c testing to support the care of veterans...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 23 awarded a $9,886.24 firm fixed price delivery order to Tosoh Bioscience, Inc. for OST PER TEST HG A1C TESTING. The place of performance is in South San Francisco, California. No set-aside designation was used for this contract. Tosoh Bioscience, Inc. will deliver glycated hemoglobin (HbA1c or A1C) testing products or services in support of the Department of Veterans Affairs' efforts to...
- 36C26319D0095Indefinite Delivery Contract
- 36C26319D0095-36C26321N0864Delivery Order
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 23 awarded Tosoh Bioscience, Inc., doing business as Tosoh USA, a $1,343.58 firm fixed price delivery order against an indefinite-delivery, indefinite-quantity contract for glycated hemoglobin A1C (HbA1c or A1C) testing services. The delivery order, which does not have a set-aside designation, requires Tosoh Bioscience to provide cost-per-test A1C testing services through September 30, 2021 for VISN 23, which oversees VA medical centers and clinics in parts of California and Nevada. The delivery order was awarded on August 23, 2021 to support VISN 23's efforts to monitor blood sugar levels in patients with diabetes.
Generated 1/3/24, 4:40 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Supplemental Agreement for work within scope | ($316) | 11/17/21 | |
| Not listed | Not listed | $1.7k | 7/27/21 |